HK
Holly B. Kordasiewicz (EVP, Chief Development Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $4.5M of IONS (60,846 sh across 2 lots, as filed), executed Jun 12. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.8M
shares × price, as filed
Last traded
Jun 12
Filed Jun 16
Median ADV $142.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
IONS
Ionis Pharmaceuticals, Inc.
IONS · 0 buys · 2 sells
2 filings
Recent filings
IONSSALE
Ionis Pharmaceuticals, Inc.
View filing →
$4.5M60,846 sh across 2 lots
Exec Jun 12
Filed Jun 16 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. View filing → $313K
4,141 sh × $75.66
Exec Jan 16
Filed Jan 20 · 5:30 PM ET